• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Hologic revenues trend downward

Article

Other headlinesCardinal Health to add radiopharmacies

Hologic revenues trend downward
Third quarter revenues dipped 6.1% at Hologic to $403.1 million from the year earlier, due primarily to falling demand for the company’s digital mammography systems. Company execs blamed the dismal economic conditions for delays and cuts in hospital capital spending. The company still generated net income of $41.0 million, albeit down from the previous year’s 3Q net income of $61.4 million. Previous success selling digital mammography units bolstered the bottom line, as the company generated a 23.8% increase in service and other revenues related primarily to its installed base of the Selenia systems. Company execs reaffirmed the low-end and tightened the top-end of its fiscal 2009 revenue guidance, predicting fourth quarter revenues between $390 million and $400 million, which would be slightly lower than those in 3Q.

Cardinal Health to add radiopharmacies
Cardinal Health has agreed to acquire the assets of privately held Biotech, an operator of PET cyclotrons and nuclear pharmacies in the U.S. Southwest. Biotech's four nuclear pharmacies, which will be acquired for an undisclosed amount, will expand Cardinal Health’s PET business in Arizona, Nevada, New Mexico and Texas. The company operates about 160 nuclear pharmacies and 26 cyclotron-based PET radiopharmaceutical manufacturing facilities.
 

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.